Peregrine Pharmaceuticals reported $44.64M in Equity Capital and Reserves for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 718.15M 44.88M
Adamas Pharmaceuticals ADMS:US -21606000 17.57M
Amgen AMGN:US $ 8217M 30M
AstraZeneca AZN:LN 39744M 24068M
Biocryst Pharmaceuticals BCRX:US $ -147.04M 40.97M
Bristol Myers Squibb BMY:US $ 37213M 405M
Celldex Therapeutics CLDX:US $ 436.71M 254.43M
Chemocentryx CCXI:US $ 315.89M 14.38M
Dicerna Pharmaceuticals DRNA:US $ 107.66M 3.41M
Eli Lilly And LLY:US $ 7757M 1312.6M
Flexion Therapeutics FLXN:US $ -82377000 26.21M
GlaxoSmithKline GSK:LN 15426M 49M
Immunogen IMGN:US $ 77.09M 8.63M
Intrexon XON:US $ 131.25M 27.95M
Karyopharm Therapeutics KPTI:US $ -125977000 42.84M
Kindred Biosciences KIN:US $ 79.77M 4.02M
Macrogenics MGNX:US $ 291.44M 27.61M
Mannkind MNKD:US $ -184.69M 1.14M
Minerva Neurosciences NERV:US $ 28.08M 8.09M
Newlink Genetics NLNK:US $ 94.12M 7M
Novartis NOVN:VX SF 56771M 2729M
Novavax NVAX:US $ 461.34M 284.23M
Peregrine Pharmaceuticals PPHM:US $ 44.64M 33.1M
Repligen RGEN:US $ 1715.26M 112.2M
Xencor XNCR:US $ 618.86M 28.08M